Manipulation of Norepinephrine Metabolism with Yohimbine in the Treatment of Autonomic Failure

作者: Italo Biaggioni , Rose Marie Robertson , David Robertson

DOI: 10.1002/J.1552-4604.1994.TB04981.X

关键词:

摘要: It has been postulated that alpha 2-adrenergic receptors play a modulatory role in the regulation of blood pressure. Activation 2-receptors located central nervous system results inhibition sympathetic tone and decrease This indeed may be mechanism action sympatholytic antihypertensives such as alpha-methyldopa. Presynaptic also are found adrenergic nerve terminals. These act negative feedback by inhibiting release norepinephrine. The relevance for pressure can explored with yohimbine, selective antagonist these receptors. Yohimbine increases resting normal volunteers. effect is associated an increase both activity, reflecting outflow, norepinephrine spillover, potentiation from actions, therefore, underscore importance even under conditions. Patients autonomic failure, those severe deprivation, hypersensitive to pressor effects yohimbine. increased responsiveness explained sensitization receptors, analogous denervation supersensitivity, lack reflexes would normally buffer any Preliminary studies suggest effectiveness yohimbine failure enhanced monoamine oxidase inhibitors. Used combination, release, whereas inhibitors inhibit its degradation. Therefore, not only useful tool study regulation, but offer therapeutic option dysfunction.

参考文章(30)
Harvey J. Motulsky, Paul A. Insel, Adrenergic Receptors in Man New England Journal of Medicine. ,vol. 307, pp. 18- 29 ,(1982) , 10.1056/NEJM198207013070104
David B. Bylund, Subtypes of alpha 1- and alpha 2-adrenergic receptors. The FASEB Journal. ,vol. 6, pp. 832- 839 ,(1992) , 10.1096/FASEBJ.6.3.1346768
W. A. Pettinger, R. M. Graham, Arthur I Sagalowsky, J. M. Schmitz, Renal alpha-1 and alpha-2 adrenergic receptors: biochemical and pharmacological correlations. Journal of Pharmacology and Experimental Therapeutics. ,vol. 219, pp. 400- 406 ,(1981)
Harvey J. Motulsky, Sanford J. Shattil, Paul A. Insel, Characterization of α2-adrenergic receptors on human platelets using [3H]yohimbine Biochemical and Biophysical Research Communications. ,vol. 97, pp. 1562- 1570 ,(1980) , 10.1016/S0006-291X(80)80044-1
J. A. Owen, S. L. Nakatsu, J. Fenemore, M. Condra, D. H. C. Surridge, A. Morales, The pharmacokinetics of yohimbine in man European Journal of Clinical Pharmacology. ,vol. 32, pp. 577- 582 ,(1987) , 10.1007/BF02455991
S. K. Guthrie, M. Hariharan, L. J. Grunhaus, Yohimbine bioavailability in humans. European Journal of Clinical Pharmacology. ,vol. 39, pp. 409- 411 ,(1990) , 10.1007/BF00315421
Brian B. Hoffman, Andre De Lean, Catherine L. Wood, Douglas D. Schocken, Robert J. Lefkowitz, Alpha-adrenergic receptor subtypes: Quantitative assessment by ligand binding Life Sciences. ,vol. 24, pp. 1739- 1745 ,(1979) , 10.1016/0024-3205(79)90061-4
L Lacomblez, G Bensimon, F Isnard, B Diquet, Y Lecrubier, A J Puech, Effect of yohimbine on blood pressure in patients with depression and orthostatic hypotension induced by clomipramine. Clinical Pharmacology & Therapeutics. ,vol. 45, pp. 241- 251 ,(1989) , 10.1038/CLPT.1989.24